Heparin-induced thrombocytopenia: Pathogenesis and management

British Journal of Haematology

Volumn 121, Issue 4, 2003, Pages 535-555

  Warkentin, Theodore E ^a  

^a HAMILTON REGIONAL LABORATORY MEDICINE PROGRAM   (Canada)

Author keywords

Antibody; Heparin; Platelet factor 4; Thrombocytopenia; Thrombosis

Indexed keywords

ARGATROBAN; COUMARIN ANTICOAGULANT; DANAPAROID; DEXTRAN; EPITOPE; FC RECEPTOR; FONDAPARINUX; HEPARIN; HEPARINOID; HIRULOG; IMMUNOGLOBULIN; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN INHIBITOR; THROMBOCYTE FACTOR 4; WARFARIN;

ANTICOAGULATION; AUTOIMMUNITY; BINDING AFFINITY; BINDING KINETICS; BLEEDING TENDENCY; CELL ACTIVATION; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE COURSE; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG EXCRETION; DRUG METABOLISM; ENDOTHELIUM CELL; GANGRENE; GENETIC POLYMORPHISM; HEART SURGERY; HUMAN; IMMUNOASSAY; LABORATORY TEST; MEDICAL DECISION MAKING; MEDICOLEGAL ASPECT; META ANALYSIS; MONOCYTE; NOMENCLATURE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PATHOGENESIS; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOSIS;

ANTIBODY FORMATION; ANTICOAGULANTS; ANTIGENS; HEMATOLOGIC TESTS; HEPARIN; HUMANS; IMMUNOGLOBULIN G; PLATELET ACTIVATION; THROMBIN; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0038392539     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04334.x     Document Type: Review

References (122)

1. Amiral, J., Bridey, F., Dreyfus, M., Vissac, A.M., Fressinaud, E., Wolf, M. & Meyer, D. (1992) Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thrombosis and Haemostasis, 68, 95-96.
2. Amiral, J., Bridey, F., Wolf, M., Boyer-Neumann, C., Fressinaud, E., Vissac, A.M., Peynaud-Debayle, E., Dreyfus, M. & Meyer, D. (1995) Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Thrombosis and Haemostasis, 73, 21-28.
3. Amiral, J., Wolf, M., Fischer, A.M., Boyer-Neumann, C., Vissac, A.M. & Meyer, D. (1996a) Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia. British Journal of Haematology, 92, 954-959.
4. Amiral, J., Marfaing-Koka, A., Wolf, M., Alessi, M.C., Tardy, B., Boyer-Neumann, C., Vissac, A.M., Fressinaud, E., Poncz, M. & Meyer, D. (1996b) Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia. Blood, 88, 410-416.
5. Amiral, J., Pernaud-Debayle, E., Wolf, M., Bridey, F., Vissac, A.M. & Meyer, D. (1996c) Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low molecular weight heparin. American Journal of Hematology, 52, 90-95.
6. Amiral, J., Lormeau, J.C., Marfaing-Koka, A., Vissac, A.M., Wolf, M., Boyer-Neumann, C., Tardy, B., Herbert, J.M. & Meyer, D. (1997) Absence of cross-reactivity of SR90107A/ORG31540 pentasaccharide with antibodies to heparin-PF4 complexes developed in heparin-induced thrombocytopenia. Blood Coagulation and Fibrinolysis, 8, 114-117.
7. Amiral, J., Pouplard, C., Vissac, A.M., Walenga, J.M., Jeske, W. & Gruel, Y. (2000) Affinity purification of heparin-dependent antibodies to platelet factor 4 developed in heparin-induced thrombocytopenia: biological characteristics and effects on platelet activation. British Journal of Haematology, 109, 336-341.
8. Aouifi, A., Blanc, P., Piriou, V., Bastien, O.H., Ffrench, P., Hanss, M. & Lehot, J.J. (2001) Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia. Annals of Thoracic Surgery, 71, 678-683.
9. Arepally, G.M. & Mayer, I.M. (2001) Antibodies from patients with heparin-induced thrombocytopenia stimulate monocytic cells to express cells to express tissue factor and secrete interleukin-8. Blood, 98, 1252-1254.
10. Bacsi, S., De Palma, R., Visentin, G.P., Gorski, J. & Aster, R.H. (1999) Complexes of heparin and platelet factor 4 specifically stimulate T cells from patients with heparin-induced thrombocytopenia/thrombosis. Blood, 94, 208-215.
11. Bacsi, S., Geoffrey, R., Visentin, G.P., De Palma, R., Aster, R.H. & Gorski, J. (2001) Identification of T cells responding to a self-protein modified by an external agent. Human Immunology, 62, 113-124.
12. Boon, D.M.S., Michiels, J.J., Stibbe, J., van Vliet, H.H.D.M. & Kappers-Klunne, M.C. (1994) Heparin-induced thrombocytopenia and antithrombotic therapy. Lancet, 344, 1296.
13. 131 polymorphism. Blood, 92, 1526-1531.
14. Chong, B.H., Burgess, J. & Ismail, F. (1993) The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia. Thrombosis and Haemostasis, 69, 344-350.
15. Chong, B.H., Murray, B., Berndt, M.C., Dunlop, L.C., Brighton, T. & Chesterman, C.N. (1994) Plasma P-selectin is increased in thrombotic consumptive platelet disorders. Blood, 83, 1535-1541.
16. Chong, B.H., Gallus, A.S., Cade, J.F., Magnani, H., Manoharan, A., Oldmeadow, M., Arthur, C., Rickard, K., Gallo, J., Lloyd, J., Seshadri, P. & Chesterman, C.N. (2001) Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopenia with thrombosis: a clinical outcome study. Thrombosis and Haemostasis, 86, 1170-1175.
17. Denomme, G.A. (2001) The platelet Fc receptor in heparin-induced thrombocytopenia. In: Heparin-induced Thrombocytopenia 2nd edn. (ed. by T.E. Warkentin & A. Greinacher), pp. 189-214. Marcel Dekker, New York.
18. 131) gene in patients with heparin-induced thrombocytopenia. Journal of Laboratory and Clinical Medicine, 130, 278-284.
19. Eichler, P., Budde, U., Haas, S., Kroll, H., Loreth, R.M., Meyer, O., Pachmann, U., Pötzsch, B., Schabel, A., Albrecht, D. & Greinacher, A. (1999) First workshop for detection of heparin-induced antibodies: validation of the heparin-induced platelet activation (HIPA) test in comparison with a PF4/heparin ELISA. Thrombosis and Haemostasis, 81, 625-629.
20. Eichler, P., Friesen, H.J., Lubenow, N., Jaeger, B. & Greinacher, A. (2000) Antihirudin antibodies in patients with heparin-induced thrombocytopenia treated with lepirudin: incidence, effects on aPTT, and clinical relevance. Blood, 96, 2373-2378.
21. Eichler, P., Raschke, R., Lubenow, N., Meyer, O., Schwind, P. & Greinacher, A. (2002a) The new ID-heparin/PF4 antibody test for rapid detection of heparin-induced antibodies in comparison with functional and antigenic assays. British Journal of Haematology, 116, 887-891.
22. Eichler, P., Lubenow, N. & Greinacher, A. (2002b) Results of the third prospective study of treatment with lepirudin in patients with heparin-induced thrombocytopenia (HAT). Blood, 100, 704a.
23. Farner, B., Eichler, P., Kroll, H. & Greinacher, A. (2001) A comparison of danaparoid and lepirudin in heparin-induced thrombocytopenia. Thrombosis and Haemostasis, 85, 950-957.
24. Fausett, M.B., Vogtlander, M., Lee, R.M., Esplin, M.S., Branch, D.W., Rodgers, G.M. & Silver, R.M. (2001) Heparin-induced thrombocytopenia is rare in pregnancy. American Journal of Obstetrics and Gynecology, 185, 148-152.
25. Fischer, K.G. (2001) Hemodialysis in heparin-induced thrombocytopenia. In: Heparin-induced Thrombocytopenia 2nd edn. (ed. by T.E. Warkentin & A. Greinacher), pp. 409-427. Marcel Dekker, New York.
26. Francis, J.L., Palmer, III, G.P., Moroose, R. & Drexler, A. (2003a) Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery. Annals of Thoracic Surgery, 75, 17-22.
27. Francis, J.L., Drexler, A., Gwyn, G. & Moroose, R. (2003b) Bivalirudin, a direct thrombin inhibitor, in the treatment of heparin-induced thrombocytopenia. Journal of Thrombosis and Haemostasis (in press).
28. Girolami, B., Prandoni, P., Stefani, P.M., Tanduo, C., Sabbion, P., Eichler, P. et al (2003) The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study. Blood, 101, 2955-2959.
29. Goad, K.E., Horne, III, M.K. & Gralnick, H.R. (1994) Pentosan-induced thrombocytopenia: support for an immune complex mechanism. British Journal of Haematology, 88, 803-808.
30. Greinacher, A. (1995) Antigen generation in heparin-associated thrombocytopenia: the nonimmunologic type and the immunologic type are closely linked in their pathogenesis. Seminars in Thrombosis and Hemostasis, 21, 106-116.
31. Greinacher, A. & Warkentin, T.E. (2001) Treatment of heparin-induced thrombocytopenia. An Overview. In: Heparin-induced Thrombocytopenia 2nd edn. (ed. by T.E. Warkentin & A. Greinacher), pp. 291-322. Marcel Dekker, New York.
32. Greinacher, A., Michels, I., Kiefel, V. & Mueller-Eckhardt, C. (1991) A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia. Thrombosis and Haemostasis, 66, 734-736.
33. Greinacher, A., Michels, I., Schafer, M., Kiefel, V. & Mueller-Eckhardt, C. (1992) Heparin-associated thrombocytopenia in a patient treated with polysulphated chondroitin sulphate: evidence for immunological crossreactivity between heparin and polysulphated glycosaminoglycan. British Journal of Haematology, 81, 252-254.
34. Greinacher, A., Michels, I., Liebenhoff, U., Presek, P. & Mueller-Eckhardt, C. (1993) Heparin-associated thrombocytopenia: immune complexes are attached to the platelet membrane by the negative charge of highly sulphated oligosaccharides. British Journal of Haematology, 84, 711-716.
35. Greinacher, A., Pötzsch, B., Amiral, J., Dummel, V., Eichner, A. & Mueller-Eckhardt, C. (1994a) Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multi-molecular PF4-heparin complex as the major antigen. Thrombosis and Haemostasis, 71, 247-251.
36. Greinacher, A., Amiral, J., Dummel, V., Vissac, A., Kiefel, V. & Mueller-Eckhardt, C. (1994b) Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay. Transfusion, 34, 381-385.
37. Greinacher, A., Liebenhoff, U., Kiefel, V., Presek, P. & Mueller- Eckhardt, C. (1994c) Heparin-associated thrombocytopenia: the effects of various intravenous IgG preparations on antibody mediated platelet activation: a possible new indication of high dose i.v. IgG. Thrombosis and Haemostasis, 71, 641-645.
38. Greinacher, A., Völpel, H., Janssens, U., Hach-Wunderle, V., Kemkes-Matthes, B., Eichler, P., Mueller-Velten, H.G. & Potzsch, B. for the HIT Investigators Group (1999a) Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia. A prospective study. Circulation, 99, 73-80.
39. Greinacher, A., Janssens, U., Berg, G., Böck, M., Kwasny, H., Kemkes-Matthes, B., Eichler, P., Völpel, H., Pötzsch, B. & Luz, M. for the Heparin-associated Thrombocytopenia Study (HAT) Investigators (1999b) Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Circulation, 100, 587-593.
40. Greinacher, A., Eichler, P., Lubenow, N., Kwasny, H. & Luz, M. (2000) Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of two prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range. Blood, 96, 846-851.
41. Hach-Wunderle, V., Kainer, K., Krug, B., Müller-Berghaus, G. & Pötzsch, B. (1994) Heparin-associated thrombosis despite normal platelet counts. Lancet, 344, 469-470.
42. Hirsh, J., Warkentin, T.E., Shaughnessy, S.G., Anand, S.S., Halperin, J.L., Raschke, R., Granger, C., Ohman, E.M. & Dalen, J.E. (2001) Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest, 119, 64s-94s.
43. Hong, A.P., Cook, D.J., Sigouin, C.S. & Warkentin, T.E. (2003) Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin-induced thrombocytopenia. Blood, 101, 3049-3051.
44. Horne, III, M.K. & Hutchison, K.J. (1998) Simultaneous binding of heparin and platelet factor-4 to platelets: further insights into the mechanism of heparin-induced thrombocytopenia. American Journal of Hematology, 58, 24-30.
45. Hughes, M., Hayward, C.P.M., Warkentin, T.E., Horsewood, P., Chorneyko, K.A. & Kelton, J.G. (2000) Morphological analysis of microparticle generation in heparin-induced thrombocytopenia. Blood, 96, 188-194.
46. Koster, A., Kukucka, M., Bach, F., Meyer, O., Fischer, T., Mertzlufft, F., Loebe, M., Hetzer, R. & Kuppe, H. (2001a) Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagnoist tirofiban. Anesthesiology, 94, 245-251.
47. Koster, A., Meyer, O., Fischer, T., Kukucka, M., Krabatsch, T., Bauer, M., Kuppe, H. & Hetzer, R. (2001b) One-year experience with the platelet glycoprotein IIb/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II. Journal of Thoracic and Cardiovascular Surgery, 122, 1254-1255.
48. Kwaan, H.C. & Sakurai, S. (1999) Endothelial cell hyperplasia contributes to thrombosis in heparin-induced thrombocytopenia. Seminars in Thrombosis and Hemostasis, 25, 23-27.
49. Lee, D.H. & Warkentin, T.E. (2001) Frequency of heparin-induced thrombocytopenia. In: Heparin-induced Thrombocytopenia 2nd edn. (ed. by T.E. Warkentin & A. Greinacher), pp. 87-121. Marcel Dekker, New York.
50. Lee, D.H., Warkentin, T.E., Denomme, G.A., Hayward, C.P.M. & Kelton, J.G. (1996) A diagnostic test for heparin-induced thrombocytopenia: detection of platelet microparticles using flow cytometry. British Journal of Haematology, 95, 724-731.
51. Lee, D.H., Warkentin, T.E., Denomme, G.A., Lagrotteria, D.D. & Kelton, J.G. (1998) Factor V Leiden and thrombotic complications in heparin-induced thrombocytopenia. Thrombosis and Haemostasis, 79, 50-53.
52. Lepercq, J., Conard, J., Borel-Derlon, A., Darmon, J.Y., Boudignat, O., Francoual, C., Priollet, P., Cohen, C., Yvelin, N., Schved, J.F., Tournaire, M. & Borg, J.Y. (2001) Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies. British Journal of Obstetrics and Gynaecology, 108, 1134-1140.
53. Lewis, B.E., Wallis, D.E., Berkowitz, S.D., Matthai, W.H., Fareed, J., Walenga, J.M., Bartholomew, J., Sham, R., Lerner, R.G., Zeigler, Z.R., Rustagi, P.K., Jang, I.K., Rifkin, S.D., Moran, J., Hursting, M.J. & Kelton, J.G. (2001) Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation, 103, 1838-1843.
54. Lewis, B.E., Matthai, Jr. W.H., Cohen, M., Moses, J.W., Hursting, M.J. & Leya, F. (2002) Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia. Catheterization and Cardiovascular Interventions, 57, 177-184.
55. Lewis, B.E., Wallis, D.E., Leya, F., Hursting, M.J. & Kelton, J.G. (2003) Argatroban anticoagulation in patients with heparin-induced thrombocytopenia. Archives of Internal Medicine (in press).
56. Li, Z.Q., Liu, W., Park, K.S., Sachais, B.S., Arepally, G.M., Cines, D.B. & Poncz, M. (2002) Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody. Blood, 99, 1230-1236.
57. Lindhoff-Last, E., Gerdsen, F., Ackermann, H. & Bauersachs, R. (2001) Determination of heparin-platelet factor 4-IgG antibodies improves diagnosis of heparin-induced thrombocytopenia. British Journal of Haematology, 113, 886-890.
58. Lindhoff-Last, E., Nakov, R., Misselwitz, F., Breddin, H.K. & Bauersachs, R. (2002) Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated heparin or low-molecular-weight heparin. British Journal of Haematology, 118, 1137-1142.
59. Ling, E. & Warkentin, T.E. (1998) Intraoperative heparin flushes and subsequent acute heparin-induced thrombocytopenia. Anesthesiology, 89, 1567-1569.
60. Lubenow, N., Eichler, P., Albrecht, D., Carlsson, L.E., Kothmann, J., Rossocha, W.R., Hahn, M., Quitman, H. & Greinacher, A. (2000) Very low platelet counts in post-transfusion purpura falsely diagnosed as heparin-induced thrombocytopenia. Report of four cases and review of literature. Thrombosis Research, 100, 115-125.
61. Lubenow, N., Kempf, R., Eichner, A., Eichler, P., Carlsson, L.E. & Greinacher, A. (2002a) Heparin-induced thrombocytopenia: temporal pattern of thrombocytopenia in relation to initial use or reexposure to heparin. Chest, 122, 37-42.
62. Lubenow, N., Eichler, P. & Greinacher, A. (2002b) Results of a large drug monitoring program confirms the safety and efficacy of Refludan (lepirudin) in patients with immune-mediated heparin-induced thrombocytopenia. Blood, 100, 502a.
63. Lubenow, N., Eichler, P., Leitz, T. & Greinacher, A. (2002c) Metaanalysis of three prospective studies of lepirudin in the prevention of thrombosis in patients with heparin-induced thrombocytopenia. Blood, 100, 501a-502a.
64. McIntyre, K. & Warkentin, T.E. (2001) Medicolegal aspects of heparin-induced thrombocytopenia: US perspective. In: Heparin-induced Thrombocytopenia 2nd edn. (ed. by T.E. Warkentin & A. Greinacher), pp. 445-456. Marcel Dekker, New York.
65. Magnani, H.N. (1993) Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with Orgaran (Org 10172). Thrombosis and Haemostasis, 70, 554-561.
66. Magnani, H.N., Beijering, R.J.R., ten Cate, J.W. & Chong, B.H. (1997) Orgaran anticoagulation for cardiopulmonary bypass in patients with heparin-induced thrombocytopenia. In: New Anticoagulants for the Cardiovascular Patient (ed. by R. Pifarre), pp. 487-500. Hanley & Belfus, Philadelphia.
67. Meyer, O., Salama, A., Pittet, N. & Schwind, P. (1999) Rapid detection of heparin-induced platelet antibodies with particle gel immunoassay (ID-HPF4). Lancet, 354, 1525-1526.
68. Newman, P.M. & Chong, B.H. (1999) Further characterization of antibody and antigen in heparin-induced thrombocytopenia. British Journal of Haematology, 107, 303-309.
69. Newman, P.M. & Chong, B.H. (2000) Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation. Blood, 96, 182-187.
70. Newman, P.M., Swanson, R.L. & Chong, B.H. (1998) Heparin-induced thrombocytopenia: IgG binding to PF4-heparin complexes in the fluid phase and cross-reactivity with low molecular weight heparin and heparinoid. Thrombosis and Haemostasis, 80, 292-297.
71. Poetzsch, B. & Madlener, K. (2001) Management of cardiopulmonary bypass anticoagulation in patients with heparin-induced thrombocytopenia. In: Heparin-induced Thrombocytopenia 2nd edn. (ed. by T.E. Warkentin & A. Greinacher), pp. 429-444. Marcel Dekker, New York.
72. Polgár, J., Eichler, P., Greinacher, A. & Clemetson, K.J. (1998) Adenosine diphosphate (ADP) and ADP receptor play a major role in platelet activation/aggregation induced by sera form heparin-induced thrombocytopenia patients. Blood, 91, 549-554.
73. Popov, D., Zarrabi, M.H., Foda, H. & Graber, M. (1997) Pseudopulmonary embolism: acute respoiratory distress in the syndrome of heparin-induced thrombocytopenia. American Journal of Kidney Diseases, 29, 449-452.
74. Pötzsch, B., Madlener, K., Seelig, C., Riess, C.F., Greinacher, A. & Müller-Berghaus, G. (1997) Monitoring of r-hirudin anticoagulation during cardiopulmonary bypass assessment of the whole blood ecarin clotting time. Thrombosis and Haemostasis, 77, 920-925.
75. Pötzsch, B., Klövekorn, W.P. & Madlener, K. (2000) Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopenia. New England Journal of Medicine, 343, 515.
76. Pouplard, C., May, M.A., Iochmann, S., Amiral, J., Vissac, A.M., Marchand, M. & Gruel, Y. (1999) Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin: clinical implications for heparin-induced thrombocytopenia. Circulation, 99, 2530-2536.
77. Pouplard, C., Iochmann, S., Renard, B., Herault, O., Colombat, P., Amiral, J. & Gruel, Y. (2001) Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia. Blood, 97, 3300-3302.
78. Ranze, O., Eichner, A., Lubenow, N., Kempf, R. & Greinacher, A. (2000) The use of low-molecular-weight heparins in heparin-induced thrombocytopenia (HIT): a cohort study. Annals of Hematology, 79, P198.
79. Reilly, M.P., Taylor, S.M., Hartman, N.K., Arepally, G.M., Sachais, B.S., Cines, D.B., Poncz, M. & McKenzie, S.E. (2001) Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcγRIIA. Blood, 98, 2442-2447.
80. Rice, L., Attisha, W.K., Drexler, A. & Francis, J.L. (2002) Delayed-onset heparin-induced thrombocytopenia. Annals of Internal Medicine, 136, 210-215.
81. Severin, T. & Sutor, A.H. (2001) Heparin-induced thrombocytopenia in pediatrics. Seminars in Thrombosis and Hemostasis, 27, 293-299.
82. Sheth, S.B., DiCicco, R.A., Hursting, M.J., Montague, T. & Jorkasky, D.K. (2001) Interpreting the International Normalized Ratio (INR) in individuals receiving argatroban and warfarin. Thrombosis and Haemostasis, 85, 435-440.
83. Smythe, M.A., Warkentin, T.E., Stephens, J.L., Zakalik, D. & Mattson, J.C. (2002) Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin-induced thrombocytopenia. American Journal of Hematology, 71, 50-52.
84. Srinivasan, A.F., Rice, L., Bartholomew, J.R., Rangaswamy, C., La Perna, L., Thompson, J.E., Murphy, S. & Baker, K.R. (2003) Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia. Archives of Internal Medicine (in press).
85. Suh, J.S., Malik, M.I., Aster, R.H. & Visentin, G.P. (1997) Characterization of the humoral immune response in heparin-induced thrombocytopenia. American Journal of Hematology, 54, 196-201.
86. Suh, J.S., Aster, R.H. & Visentin, G.P. (1998) Antibodies from patients with heparin-induced thrombocytopenia/thrombosis recognize different epitopes on heparin: platelet factor 4. Blood, 91, 916-922.
87. Tardy, B., Tardy-Poncet, B., Fournel, P., Venet, C., Jospe, R. & Dacosta, A. (1999) Lower limb veins should be systematically explored in patients with isolated heparin-induced thrombocytopenia. Thrombosis and Haemostasis, 82, 1199-1200.
88. Visentin, G.P., Ford, S.E., Scott, J.P. & Aster, R.H. (1994) Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. Journal of Clinical Investigation, 93, 81-88.
89. Visentin, G.P., Moghaddam, M., Beery, S.E., McFarland, J.G. & Aster, R.H. (2001) Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis. Journal of Laboratory and Clinical Medicine, 138, 22-31.
90. Wallis, D.E., Workman, D.L., Lewis, B.E., Steen, L., Pifarre, R. & Moran, J.F. (1999) Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia. American Journal of Medicine, 106, 629-635.
91. Warkentin, T.E. (1996a) Heparin-induced skin lesions. British Journal of Haematology, 92, 494-497.
92. Warkentin, T.E. (1996b) Heparin-induced thrombocytopenia: IgG-mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-induced thrombocytopenia. Transfusion Medicine Reviews, 10, 249-258.
93. Warkentin, T.E. (1996c) Danaparoid (Orgaran) for the treatment of heparin-induced thrombocytopenia (HIT) and thrombosis: effects on in vivo thrombin and cross-linked fibrin generation, and evaluation of the clinical significance of in vitro cross-reactivity (SR) of danaparoid for HIT-IgG. Blood, 88, 626a.
94. Warkentin, T.E. (2001a) Pseudo-heparin-induced thrombocytopenia. In: Heparin-induced Thrombocytopenia 2nd edn. (ed. by T.E. Warkentin & A. Greinacher), pp. 271-289. Marcel Dekker, New York.
95. Warkentin, T.E. (2001b) History of heparin-induced thrombocytopenia. In: Heparin-induced Thrombocytopenia 2nd edn. (ed. by T.E. Warkentin & A. Greinacher), pp. 1-18. Marcel Dekker, New York.
96. Warkentin, T.E. (2001c) Clinical picture of heparin-induced thrombocytopenia. In: Heparin-induced Thrombocytopenia 2nd edn. (ed. by T.E. Warkentin & A. Greinacher), pp. 43-86. Marcel Dekker, New York.
97. Warkentin, T.E. (2001d) Heparin-induced thrombocytopenia: yet another treatment paradox? Thrombosis and Haemostasis, 85, 947-949.
98. Warkentin, T.E. (2001e) Venous limb gangrene during warfarin treatment of cancer-associated deep venous thrombosis. Annals of Internal Medicine, 135, 589-593.
99. Warkentin, T.E. (2002a) Platelet count monitoring and laboratory testing for heparin-induced thrombocytopenia. Archives of Pathology and Laboratory Medicine, 126, 1415-1423.
100. Warkentin, T.E. (2002b) Heparin-induced thrombocytopenia. Current Hematology Reports, 1, 63-72.
101. Warkentin, T.E. (2002c) Heparin-induced thrombocytopenia for the anesthesiologist. Canadian Journal of Anesthesia, 49, s36-s39.
102. Warkentin, T.E. (2002d) Heparin-induced thrombocytopenia, part 2: clinical course and treatment. Journal of Critical Illness, 17, 215-221.
103. Warkentin, T.E. & Bernstein, R.A. (2003) Delayed-onset heparin-induced thrombocytopenia and cerebral thrombosis following a single administration of unfractionated heparin. New England Journal of Medicine (in press).
104. Warkentin, T.E. & Greinacher, A. (2001) Laboratory testing for heparin-induced thrombocytopenia. In: Heparin-induced Thrombocytopenia 2nd edn. (ed. by T.E. Warkentin & A. Greinacher), pp. 231-269. Marcel Dekker, New York.
105. Warkentin, T.E. & Greinacher, A. (2003) Heparin-induced thrombocytopenia and cardiac surgery. Annals of Thoracic Surgery (in press).
106. Warkentin, T.E. & Heddle, N.M. (2003) Laboratory diagnosis of immune heparin-induced thrombocytopenia. Current Hematology Reports, 2, 148-157.
107. Warkentin, T.E. & Kelton, J.G. (1996) A 14-year study of heparin-induced thrombocytopenia. American Journal of Medicine, 101, 502-507.
108. Warkentin, T.E. & Kelton, J.G. (2001a) Delayed-onset heparin-induced thrombocytopenia and thrombosis. Annals of Internal Medicine, 135, 502-506.
109. Warkentin, T.E. & Kelton, J.G. (2001b) Temporal aspects of heparin-induced thrombocytopenia. New England Journal of Medicine, 344, 1286-1292.
110. Warkentin, T.E. & Sheppard, J.I. (1999) Generation of platelet-derived microparticles and procoagulant activity by heparin-induced thrombocytopenia IgG/serum and other IgG platelet agonists; a comparison with standard platelet agonists. Platelets, 10, 319-326.
111. Warkentin, T.E. & Sigouin, C.S. (2002) Gender and risk of immune heparin-induced thrombocytopenia. Blood, 100, 17a.
112. Warkentin, T.E., Hayward, C.P.M., Smith, C.A., Kelly, P.M. & Kelton, J.G. (1992) Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia. Journal of Laboratory and Clinical Medicine, 120, 371-379.
113. Warkentin, T.E., Hayward, C.P.M., Boshkov, L.K., Santos, A.V., Sheppard, J.I., Bode, A.P. & Kelton, J.G. (1994a) Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood, 84, 3691-3699.
114. Warkentin, T.E., Hirte, H.W., Anderson, D.R., Wilson, W.E.C., O'Connell, G.J. & Lo, R.C. (1994b) Transient global amnesia associated with acute heparin-induced thrombocytopenia. American Journal of Medicine, 97, 489-491.
115. Warkentin, T.E., Levine, M.N., Hirsh, J., Horsewood, P., Roberts, R.S., Gent, M. & Kelton, J.G. (1995) Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. New England Journal of Medicine, 332, 1330-1335.
116. Warkentin, T.E., Elavathil, L.J., Hayward, C.P.M., Johnston, M.A., Russett, J.I. & Kelton, J.G. (1997) The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia. Annals of Internal Medicine, 127, 804-812.
117. Warkentin, T.E., Chong, B.H. & Greinacher, A. (1998) Heparin-induced thrombocytopenia: towards consensus. Thrombosis and Haemostasis, 79, 1-7.
118. Warkentin, T.E., Sikov, W.M. & Lillicrap, D.P. (1999) Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopenia. American Journal of Hematology, 62, 44-48.
119. Warkentin, T.E., Sheppard, J.I., Horsewood, P., Simpson, P.J., Moore, J.C. & Kelton, J.G. (2000) Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood, 96, 1703-1708.
120. Warkentin, T.E., Dunn, G.L. & Cybulsky, I.J. (2001) Off-pump coronary artery bypass grafting for acute heparin-induced thrombocytopenia. Annals of Thoracic Surgery, 72, 1730-1732.
121. Warkentin, T.E., Roberts, R.S., Hirsch, J. & Kelton, J.G. (2003) An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients. Archives of Internal Medicine (in press).
122. Ziporen, L., Li, Z.Q., Park, K.S., Sabnekar, P., Liu, W.Y., Arepally, G., Schoenfeld, Y., Kieber-Emmons, T., Cines, D.B. & Poncz, M. (1998) Defining an antigenic epitope on platelet factor 4 associated with heparin-induced thrombocytopenia. Blood, 92, 3250-3259.